HTS for Small Molecule Modulators of RGS Proteins
HTS for Small Molecule Modulators of RGS Proteins
批准号:
7054988
负责人:
David L. Roman
金额:
$4.6万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-01 至 2008-01-31
关键词:
DNA binding proteinbiological signal transductioncell surface receptorschemical registry /resourcecombinatorial chemistrydrug screening /evaluationflow cytometryguanosinetriphosphatase activating proteinhigh throughput technologyinhibitor /antagonistphosphatidylinositolspostdoctoral investigatorprotein protein interactionprotein structureprotein structure functionsecond messengers
中文摘要
描述(由申请人提供):G蛋白信号传导(RGS)蛋白的调节剂是通过G蛋白偶联受体(gpcr)启动的信号的重要调节剂。RGS蛋白的作用是通过调节G?加速G蛋白信号的失活。亚基GTPase活性,导致信号终止。虽然gpcr一直是经典的药物靶点,但许多细胞过程可以通过改变RGS蛋白的作用来调节。我建议使用一种新的高通量流式细胞术方法来测量各种RGS蛋白与其效应蛋白(即G?)的相互作用亲和力。建立这些参数后,将使用高通量流式细胞术筛选不同化合物库(~35,000),以确定RGS活性的调节剂。一旦确定了调节剂,将评估完整的定量结构-活性关系,并在生化和基于细胞的分析中对其他类似化合物进行表征。这些药理调节剂的使用将为研究RGS蛋白可能发挥作用的各种疾病提供实用工具,包括帕金森病(RGS9)、精神分裂症(RGS4)以及细胞增殖和转移(LARG)。
英文摘要
DESCRIPTION (provided by applicant): Regulators of G-protein signaling (RGS) proteins are important modulators of signals initiated through G- protein coupled receptors (GPCRs). The action of RGS proteins is the acceleration of the deactivation of G- protein signals through modulation of G? subunit GTPase activity, which causes a termination of signal. While GPCRs have been classical drug targets, many cellular processes can be modulated by altering the action of RGS proteins. I propose to measure the interaction affinity of a variety of RGS proteins for their effector proteins (i.e. G?) using a novel high throughput flow cytometric method. With these parameters established, a library of diverse chemical compounds (~35,000) will be screened to identify modulators of RGS activity using the high throughput flow cytometric method. Once modulators are identified, complete quantitative structure-activity relationships will be evaluated and additional similar compounds will be characterized in both biochemical and cell-based assays. The use of these pharmacological modulators would provide utility for studying various disease in which RGS proteins could play a role, including Parkinson's disease (RGS9), Schizophrenia (RGS4), as well as cell proliferation and metastasis (LARG).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predoctoral Training in the Pharmacological Sciences
-
批准号:10347969
-
项目类别:
-
资助金额:$38.82万
-
财政年份:2022
-
负责人:David L. Roman
-
依托单位:
Predoctoral Training in the Pharmacological Sciences
-
批准号:10621722
-
项目类别:
-
资助金额:$39.73万
-
财政年份:2022
-
负责人:David L. Roman
-
依托单位:
Non-opioids for inflammatory pain: Adenylyl cyclase 1 as a novel target
-
批准号:10397712
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2021
-
负责人:David L. Roman
-
依托单位:
Non-Opioids for Inflammatory Pain: Adenylyl Cyclase 1 as a Novel Target
-
批准号:10525509
-
项目类别:
-
资助金额:$6.01万
-
财政年份:2021
-
负责人:David L. Roman
-
依托单位:
Non-Opioids for Inflammatory Pain: Adenylyl Cyclase 1 as a Novel Target
-
批准号:10405130
-
项目类别:
-
资助金额:$40.9万
-
财政年份:2021
-
负责人:David L. Roman
-
依托单位:
Biochemical and Cell-Based HTS Assays for RGS17 Inhibitors
-
批准号:8626364
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2012
-
负责人:David L. Roman
-
依托单位:
Biochemical and Cell-Based HTS Assays for RGS17 Inhibitors
-
批准号:8462940
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2012
-
负责人:David L. Roman
-
依托单位:
Biochemical and Cell-Based HTS Assays for RGS17 Inhibitors
-
批准号:8242653
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2012
-
负责人:David L. Roman
-
依托单位:
HTS for Small Molecule Modulators of RGS Proteins
-
批准号:7188563
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2006
-
负责人:David L. Roman
-
依托单位:
High Throughput Screening
-
批准号:10395534
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:David L. Roman
-
依托单位:
High Throughput Screening
-
批准号:10600155
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:David L. Roman
-
依托单位:
海外基金